Qingdao Haier Biomedical Co.,Ltd (SHA:688139)

SHA:688139 Revenue

Qingdao Haier Biomedical Co.,Ltd had revenue of 667.49M CNY in the quarter ending September 30, 2026, with 18.00% growth. This brings the company's total for the last twelve months to 2.53B, up 11.86% year-over-year. In the year 2025, Qingdao Haier Biomedical Co.,Ltd had annual revenue of 2.33B with 1.96% growth. That makes Qingdao Haier Biomedical Co.,Ltd the 12,974th largest company in the world by revenue and 2,264th in China.

• Revenue (ttm): 2.53B
• Revenue Growth: +11.86%
• P/S Ratio: 3.84
• Revenue / Employee: 859.58K
• Employees: 2,887
• Market Cap: 9.73B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Mainland China 1.48B 63.6%
• Others 848.27M 36.4%

Fiscal year ended Dec 31, 2025 See the full SHA:688139 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.33B	44.84M	1.96%
Dec 31, 2024	2.28B	2.94M	0.13%
Dec 31, 2023	2.28B	-583.15M	-20.36%
Dec 31, 2022	2.86B	738.18M	34.72%
Dec 31, 2021	2.13B	723.83M	51.63%

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 14, 2026

Data Sources Report a data error